MR 409

CAT: 0804-HY-P3304-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-P3304-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
MR 409 is a selected growth hormone-releasing hormone (GHRH) agonist. MR 409 has remarkable neuroprotective effects through enhancing endogenous neurogenesis in cerebral ischemic mice. MR 409 also inhibits the in vivo growth of lung cancer[1][2][3][4].
CAS Number
[1445155-39-4]
UNSPSC
12352209
Target
GHSR
Type
Peptides
Related Pathways
GPCR/G Protein
Applications
Cancer-programmed cell death
Field of Research
Cancer; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/mr-409.html
Purity
99.51
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : ≥ 50 mg/mL
Smiles
[C@@H](CC1=CC=CC=C1)(NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](NC([C@H](CC2=CC=C(O)C=C2)NC)=O)C)=O)CC(O)=O)=O)C)=O)[C@H](CC)C)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC3=CC=C(O)C=C3)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CCCNC(=N)N)C(NC)=O)=O)CC(O)=O)=O)CCCC)=O)[C@H](CC)C)=O)CC(O)=O)=O)CCC(N)=O)=O)CC(C)C)=O)CC(C)C)=O)CCCN)=O)CCCNC(=N)N)=O)C)=O)CO)=O)CC(C)C)=O)CCC(N)=O)=O)CC)=O)CC(C)C)=O)[C@H](C)C)=O)CCCN)=O)CCCNC(=N)N)=O)=O)CO)=O)CC(N)=O)=O)[C@@H](C)O)=O
Molecular Formula
C153H252N44O43
Molecular Weight
3395.91
References & Citations
[1]Rosemeire M Kanashiro-Takeuchi, et al. New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor. Oncotarget. 2015;6 (12) :9728-39.|[2]Mohammad A Uddin, et al. GHRH antagonists support lung endothelial barrier function. Tissue Barriers. 2019;7 (4) :1669989.|[3]Lucia Recinella, et al. Protective effects of growth hormone-releasing hormone analogs in DSS-induced colitis in mice. Sci Rep. 2021 Jan 28;11 (1) :2530.|[4]Yueyang Liu, et al. Agonistic analog of growth hormone-releasing hormone promotes neurofunctional recovery and neural regeneration in ischemic stroke. Proc Natl Acad Sci U S A. 2021 Nov 23;118 (47) :e2109600118.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)
Scientific Category
Peptides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-110057-01FR 409
HY-158113-01CBPD-409
HY-170952-01LYG-409
HY-19090FK 409
HY-128358-01MR-L2
HY-162100MR-2088
HY-W999558CRBN ligand-409
HY-100981MR-16728 (hydrochloride)
HY-RI00918A-01Hsa-miR-409-5p antagomir
HY-RI00917A-01Hsa-miR-409-3p antagomir

Alternative Products

CatalogName
MBS1412277-01Recombinant Rat Protein PRRC1 (Prrc1)
MBS1412275-01Recombinant Danio rerio Mediator of RNA polymerase II transcription subunit 30 (med30)
MBS1412271-01Recombinant Yersinia pestis bv. Antiqua Iron-sulfur cluster repair protein YtfE (ytfE)
MBS1407862-01Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai Holo-[acyl-carrier-protein] synthase (acpS)
MBS1412255-01Recombinant Streptococcus pyogenes serotype M6 30S ribosomal protein S20 (rpsT)
MBS1407861-01Recombinant Sulfolobus acidocaldarius CCA-adding enzyme (cca)
MBS1412252-01Recombinant Staphylococcus aureus tRNA modification GTPase MnmE (mnmE)
MBS1412248-01Recombinant Neurospora crassa Adenylate kinase 1 (adk-1)
MBS1412246-01Recombinant Phalaenopsis aphrodite subsp. formosana DNA-directed RNA polymerase subunit alpha (rpoA)
MBS1412244-01Recombinant Nitrosomonas europaea Lipoprotein-releasing system ATP-binding protein LolD (lolD)

Popular Products